BGLC

BioNexus Gene Lab Corp. NASDAQ Listed Jan 8, 2021

Healthcare ·Medical - Diagnostics & Research ·MY · bionexusgenelab.com

$2.13

Mkt Cap $4.0M

52w Low $1.92 1.5% of range 52w High $15.60

50d MA $2.31 200d MA $3.99

P/E (TTM) -1.3x

EV/EBITDA -1.8x

P/B 0.5x

Debt/Equity 0.0x

ROE -34.6%

P/FCF -3.9x

RSI (14) —

ATR (14) —

Beta 2.31

50d MA $2.31

200d MA $3.99

Avg Volume 19.3K

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

CIK (SEC)

1737523

Phone

60 1 2212 6512

Tower B, Vertical Business Suite · Kuala Lumpur 59200 · MY

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 14, 2026	AMC	—	-0.52	—	2.17	+6.5%	+0.5%	+0.0%	+0.9%	+3.6%	-0.9%	—
Nov 14, 2025	AMC	—	-0.39	—	4.53	-1.3%	+3.3%	+2.8%	-0.4%	-9.2%	+2.5%	—
Aug 18, 2025	AMC	—	-0.34	—	5.32	+0.8%	+0.0%	+0.2%	+7.3%	-1.6%	+0.2%	—
May 15, 2025	AMC	—	-0.03	—	3.04	-4.3%	-6.2%	-5.6%	+3.3%	+7.2%	-5.0%	—
Apr 15, 2025	AMC	—	-0.19	—	2.65	-2.6%	+0.8%	+2.2%	-2.2%	+4.5%	+3.6%	—
Nov 15, 2024	AMC	—	-0.20	—	3.00	-3.0%	-2.3%	-2.4%	+4.9%	-2.7%	-0.3%	—
Aug 14, 2024	AMC	—	0.10	—	4.42	+0.9%	-5.0%	-1.0%	+3.4%	-3.3%	+4.3%	—
May 31, 2024	AMC	—	-0.18	—	4.25	+4.9%	+3.5%	+12.7%	+0.8%	+20.2%	-7.5%	—
May 15, 2024	AMC	—	-0.18	—	5.80	+2.2%	-1.7%	+0.7%	-0.5%	-5.3%	+0.9%	—

Data updated apr 24, 2026 9:23pm · Source: massive.com